nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Carboplatin—breast cancer	0.116	1	CbGbCtD
Octreotide—SSTR4—female reproductive system—breast cancer	0.00837	0.0961	CbGeAlD
Octreotide—SSTR5—pituitary gland—breast cancer	0.00777	0.0892	CbGeAlD
Octreotide—SSTR4—female gonad—breast cancer	0.00762	0.0874	CbGeAlD
Octreotide—SSTR3—pituitary gland—breast cancer	0.00745	0.0856	CbGeAlD
Octreotide—SSTR4—endocrine gland—breast cancer	0.00708	0.0813	CbGeAlD
Octreotide—SSTR5—endocrine gland—breast cancer	0.00602	0.0691	CbGeAlD
Octreotide—SSTR1—pituitary gland—breast cancer	0.00589	0.0676	CbGeAlD
Octreotide—SSTR3—endocrine gland—breast cancer	0.00577	0.0663	CbGeAlD
Octreotide—SSTR1—female reproductive system—breast cancer	0.00539	0.0619	CbGeAlD
Octreotide—SSTR2—pituitary gland—breast cancer	0.00501	0.0575	CbGeAlD
Octreotide—SSTR1—endocrine gland—breast cancer	0.00456	0.0524	CbGeAlD
Octreotide—SSTR2—endocrine gland—breast cancer	0.00388	0.0445	CbGeAlD
Octreotide—MPO—epithelium—breast cancer	0.00234	0.0268	CbGeAlD
Octreotide—MPO—skin of body—breast cancer	0.00222	0.0255	CbGeAlD
Octreotide—MPO—pituitary gland—breast cancer	0.0019	0.0218	CbGeAlD
Octreotide—MPO—adrenal gland—breast cancer	0.00169	0.0195	CbGeAlD
Octreotide—MPO—bone marrow—breast cancer	0.00164	0.0188	CbGeAlD
Octreotide—MPO—endocrine gland—breast cancer	0.00147	0.0169	CbGeAlD
Octreotide—MPO—lymph node—breast cancer	0.00102	0.0117	CbGeAlD
Octreotide—Desmopressin—PTGS1—breast cancer	0.000141	0.636	CrCbGaD
Octreotide—Desmopressin—PTGS2—breast cancer	8.07e-05	0.364	CrCbGaD
Octreotide—Flushing—Epirubicin—breast cancer	6.17e-05	0.000126	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—breast cancer	6.17e-05	0.000126	CcSEcCtD
Octreotide—Vomiting—Fluorouracil—breast cancer	6.17e-05	0.000126	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—breast cancer	6.17e-05	0.000126	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—breast cancer	6.16e-05	0.000126	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—breast cancer	6.15e-05	0.000126	CcSEcCtD
Octreotide—Insomnia—Capecitabine—breast cancer	6.13e-05	0.000125	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—breast cancer	6.12e-05	0.000125	CcSEcCtD
Octreotide—Rash—Fluorouracil—breast cancer	6.12e-05	0.000125	CcSEcCtD
Octreotide—Dermatitis—Fluorouracil—breast cancer	6.11e-05	0.000125	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—breast cancer	6.11e-05	0.000125	CcSEcCtD
Octreotide—Paraesthesia—Capecitabine—breast cancer	6.09e-05	0.000124	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—breast cancer	6.09e-05	0.000124	CcSEcCtD
Octreotide—Hypersensitivity—Paclitaxel—breast cancer	6.09e-05	0.000124	CcSEcCtD
Octreotide—Headache—Fluorouracil—breast cancer	6.08e-05	0.000124	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—breast cancer	6.06e-05	0.000124	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—breast cancer	6.05e-05	0.000124	CcSEcCtD
Octreotide—Dyspnoea—Capecitabine—breast cancer	6.05e-05	0.000124	CcSEcCtD
Octreotide—Fatigue—Docetaxel—breast cancer	6.04e-05	0.000123	CcSEcCtD
Octreotide—Nausea—Mitoxantrone—breast cancer	6.02e-05	0.000123	CcSEcCtD
Octreotide—Nausea—Irinotecan—breast cancer	6.02e-05	0.000123	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—breast cancer	6.01e-05	0.000123	CcSEcCtD
Octreotide—Constipation—Docetaxel—breast cancer	5.99e-05	0.000122	CcSEcCtD
Octreotide—Pain—Docetaxel—breast cancer	5.99e-05	0.000122	CcSEcCtD
Octreotide—Back pain—Methotrexate—breast cancer	5.98e-05	0.000122	CcSEcCtD
Octreotide—Dyspepsia—Capecitabine—breast cancer	5.97e-05	0.000122	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—breast cancer	5.94e-05	0.000121	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—breast cancer	5.93e-05	0.000121	CcSEcCtD
Octreotide—Asthenia—Paclitaxel—breast cancer	5.93e-05	0.000121	CcSEcCtD
Octreotide—Decreased appetite—Capecitabine—breast cancer	5.89e-05	0.000121	CcSEcCtD
Octreotide—Alopecia—Epirubicin—breast cancer	5.88e-05	0.00012	CcSEcCtD
Octreotide—Nausea—Gemcitabine—breast cancer	5.86e-05	0.00012	CcSEcCtD
Octreotide—Gastrointestinal disorder—Capecitabine—breast cancer	5.85e-05	0.00012	CcSEcCtD
Octreotide—Fatigue—Capecitabine—breast cancer	5.85e-05	0.00012	CcSEcCtD
Octreotide—Pruritus—Paclitaxel—breast cancer	5.85e-05	0.00012	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—breast cancer	5.83e-05	0.000119	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—breast cancer	5.83e-05	0.000119	CcSEcCtD
Octreotide—Constipation—Capecitabine—breast cancer	5.8e-05	0.000119	CcSEcCtD
Octreotide—Pain—Capecitabine—breast cancer	5.8e-05	0.000119	CcSEcCtD
Octreotide—Erythema—Epirubicin—breast cancer	5.79e-05	0.000118	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—breast cancer	5.79e-05	0.000118	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—breast cancer	5.77e-05	0.000118	CcSEcCtD
Octreotide—Nausea—Fluorouracil—breast cancer	5.76e-05	0.000118	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—breast cancer	5.74e-05	0.000117	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—breast cancer	5.74e-05	0.000117	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—breast cancer	5.73e-05	0.000117	CcSEcCtD
Octreotide—Anaemia—Methotrexate—breast cancer	5.72e-05	0.000117	CcSEcCtD
Octreotide—Flushing—Doxorubicin—breast cancer	5.71e-05	0.000117	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—breast cancer	5.71e-05	0.000117	CcSEcCtD
Octreotide—Flatulence—Epirubicin—breast cancer	5.7e-05	0.000117	CcSEcCtD
Octreotide—Tension—Epirubicin—breast cancer	5.68e-05	0.000116	CcSEcCtD
Octreotide—Diarrhoea—Paclitaxel—breast cancer	5.65e-05	0.000116	CcSEcCtD
Octreotide—Nervousness—Epirubicin—breast cancer	5.62e-05	0.000115	CcSEcCtD
Octreotide—Back pain—Epirubicin—breast cancer	5.6e-05	0.000114	CcSEcCtD
Octreotide—Feeling abnormal—Capecitabine—breast cancer	5.59e-05	0.000114	CcSEcCtD
Octreotide—Malaise—Methotrexate—breast cancer	5.58e-05	0.000114	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—breast cancer	5.56e-05	0.000114	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—breast cancer	5.56e-05	0.000114	CcSEcCtD
Octreotide—Vertigo—Methotrexate—breast cancer	5.56e-05	0.000114	CcSEcCtD
Octreotide—Gastrointestinal pain—Capecitabine—breast cancer	5.54e-05	0.000113	CcSEcCtD
Octreotide—Abdominal pain—Docetaxel—breast cancer	5.54e-05	0.000113	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—breast cancer	5.54e-05	0.000113	CcSEcCtD
Octreotide—Arrhythmia—Doxorubicin—breast cancer	5.5e-05	0.000112	CcSEcCtD
Octreotide—Dizziness—Paclitaxel—breast cancer	5.46e-05	0.000112	CcSEcCtD
Octreotide—Vision blurred—Epirubicin—breast cancer	5.45e-05	0.000112	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—breast cancer	5.44e-05	0.000111	CcSEcCtD
Octreotide—Cough—Methotrexate—breast cancer	5.4e-05	0.00011	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—breast cancer	5.39e-05	0.00011	CcSEcCtD
Octreotide—Urticaria—Capecitabine—breast cancer	5.39e-05	0.00011	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—breast cancer	5.37e-05	0.00011	CcSEcCtD
Octreotide—Abdominal pain—Capecitabine—breast cancer	5.36e-05	0.00011	CcSEcCtD
Octreotide—Body temperature increased—Capecitabine—breast cancer	5.36e-05	0.00011	CcSEcCtD
Octreotide—Convulsion—Methotrexate—breast cancer	5.36e-05	0.00011	CcSEcCtD
Octreotide—Erythema—Doxorubicin—breast cancer	5.36e-05	0.000109	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—breast cancer	5.36e-05	0.000109	CcSEcCtD
Octreotide—Anaemia—Epirubicin—breast cancer	5.35e-05	0.000109	CcSEcCtD
Octreotide—Agitation—Epirubicin—breast cancer	5.32e-05	0.000109	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—breast cancer	5.28e-05	0.000108	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—breast cancer	5.27e-05	0.000108	CcSEcCtD
Octreotide—Myalgia—Methotrexate—breast cancer	5.27e-05	0.000108	CcSEcCtD
Octreotide—Chest pain—Methotrexate—breast cancer	5.27e-05	0.000108	CcSEcCtD
Octreotide—Tension—Doxorubicin—breast cancer	5.26e-05	0.000107	CcSEcCtD
Octreotide—Vomiting—Paclitaxel—breast cancer	5.25e-05	0.000107	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.23e-05	0.000107	CcSEcCtD
Octreotide—Malaise—Epirubicin—breast cancer	5.22e-05	0.000107	CcSEcCtD
Octreotide—Rash—Paclitaxel—breast cancer	5.21e-05	0.000107	CcSEcCtD
Octreotide—Dermatitis—Paclitaxel—breast cancer	5.2e-05	0.000106	CcSEcCtD
Octreotide—Discomfort—Methotrexate—breast cancer	5.2e-05	0.000106	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—breast cancer	5.2e-05	0.000106	CcSEcCtD
Octreotide—Vertigo—Epirubicin—breast cancer	5.2e-05	0.000106	CcSEcCtD
Octreotide—Syncope—Epirubicin—breast cancer	5.19e-05	0.000106	CcSEcCtD
Octreotide—Back pain—Doxorubicin—breast cancer	5.18e-05	0.000106	CcSEcCtD
Octreotide—Headache—Paclitaxel—breast cancer	5.18e-05	0.000106	CcSEcCtD
Octreotide—Hypersensitivity—Docetaxel—breast cancer	5.16e-05	0.000105	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—breast cancer	5.15e-05	0.000105	CcSEcCtD
Octreotide—Palpitations—Epirubicin—breast cancer	5.11e-05	0.000105	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—breast cancer	5.09e-05	0.000104	CcSEcCtD
Octreotide—Cough—Epirubicin—breast cancer	5.05e-05	0.000103	CcSEcCtD
Octreotide—Anaphylactic shock—Methotrexate—breast cancer	5.05e-05	0.000103	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—breast cancer	5.05e-05	0.000103	CcSEcCtD
Octreotide—Asthenia—Docetaxel—breast cancer	5.02e-05	0.000103	CcSEcCtD
Octreotide—Convulsion—Epirubicin—breast cancer	5.01e-05	0.000103	CcSEcCtD
Octreotide—Infection—Methotrexate—breast cancer	5.01e-05	0.000103	CcSEcCtD
Octreotide—Hypertension—Epirubicin—breast cancer	5e-05	0.000102	CcSEcCtD
Octreotide—Hypersensitivity—Capecitabine—breast cancer	5e-05	0.000102	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—breast cancer	4.97e-05	0.000102	CcSEcCtD
Octreotide—Pruritus—Docetaxel—breast cancer	4.95e-05	0.000101	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—breast cancer	4.95e-05	0.000101	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—breast cancer	4.95e-05	0.000101	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—breast cancer	4.94e-05	0.000101	CcSEcCtD
Octreotide—Chest pain—Epirubicin—breast cancer	4.93e-05	0.000101	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—breast cancer	4.93e-05	0.000101	CcSEcCtD
Octreotide—Myalgia—Epirubicin—breast cancer	4.93e-05	0.000101	CcSEcCtD
Octreotide—Agitation—Doxorubicin—breast cancer	4.92e-05	0.000101	CcSEcCtD
Octreotide—Anxiety—Epirubicin—breast cancer	4.91e-05	0.0001	CcSEcCtD
Octreotide—Nausea—Paclitaxel—breast cancer	4.91e-05	0.0001	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—breast cancer	4.9e-05	0.0001	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.89e-05	0.0001	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—breast cancer	4.88e-05	9.98e-05	CcSEcCtD
Octreotide—Discomfort—Epirubicin—breast cancer	4.87e-05	9.95e-05	CcSEcCtD
Octreotide—Asthenia—Capecitabine—breast cancer	4.86e-05	9.95e-05	CcSEcCtD
Octreotide—Malaise—Doxorubicin—breast cancer	4.83e-05	9.87e-05	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—breast cancer	4.82e-05	9.85e-05	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—breast cancer	4.81e-05	9.84e-05	CcSEcCtD
Octreotide—Anorexia—Methotrexate—breast cancer	4.81e-05	9.84e-05	CcSEcCtD
Octreotide—Syncope—Doxorubicin—breast cancer	4.8e-05	9.82e-05	CcSEcCtD
Octreotide—Pruritus—Capecitabine—breast cancer	4.8e-05	9.81e-05	CcSEcCtD
Octreotide—Diarrhoea—Docetaxel—breast cancer	4.79e-05	9.8e-05	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—breast cancer	4.73e-05	9.68e-05	CcSEcCtD
Octreotide—Oedema—Epirubicin—breast cancer	4.72e-05	9.66e-05	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—breast cancer	4.72e-05	9.66e-05	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—breast cancer	4.71e-05	9.62e-05	CcSEcCtD
Octreotide—Infection—Epirubicin—breast cancer	4.69e-05	9.59e-05	CcSEcCtD
Octreotide—Cough—Doxorubicin—breast cancer	4.67e-05	9.55e-05	CcSEcCtD
Octreotide—Shock—Epirubicin—breast cancer	4.65e-05	9.5e-05	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—breast cancer	4.64e-05	9.49e-05	CcSEcCtD
Octreotide—Diarrhoea—Capecitabine—breast cancer	4.64e-05	9.48e-05	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—breast cancer	4.63e-05	9.47e-05	CcSEcCtD
Octreotide—Dizziness—Docetaxel—breast cancer	4.63e-05	9.47e-05	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—breast cancer	4.63e-05	9.46e-05	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—breast cancer	4.62e-05	9.45e-05	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—breast cancer	4.61e-05	9.43e-05	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methotrexate—breast cancer	4.6e-05	9.4e-05	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—breast cancer	4.59e-05	9.38e-05	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—breast cancer	4.57e-05	9.34e-05	CcSEcCtD
Octreotide—Insomnia—Methotrexate—breast cancer	4.57e-05	9.33e-05	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—breast cancer	4.56e-05	9.32e-05	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—breast cancer	4.56e-05	9.32e-05	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—breast cancer	4.56e-05	9.32e-05	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—breast cancer	4.54e-05	9.29e-05	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—breast cancer	4.53e-05	9.27e-05	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.53e-05	9.26e-05	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—breast cancer	4.5e-05	9.21e-05	CcSEcCtD
Octreotide—Anorexia—Epirubicin—breast cancer	4.5e-05	9.21e-05	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—breast cancer	4.5e-05	9.2e-05	CcSEcCtD
Octreotide—Somnolence—Methotrexate—breast cancer	4.49e-05	9.17e-05	CcSEcCtD
Octreotide—Dizziness—Capecitabine—breast cancer	4.48e-05	9.17e-05	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—breast cancer	4.46e-05	9.12e-05	CcSEcCtD
Octreotide—Vomiting—Docetaxel—breast cancer	4.45e-05	9.1e-05	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—breast cancer	4.44e-05	9.08e-05	CcSEcCtD
Octreotide—Rash—Docetaxel—breast cancer	4.42e-05	9.03e-05	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—breast cancer	4.41e-05	9.02e-05	CcSEcCtD
Octreotide—Decreased appetite—Methotrexate—breast cancer	4.39e-05	8.97e-05	CcSEcCtD
Octreotide—Headache—Docetaxel—breast cancer	4.39e-05	8.97e-05	CcSEcCtD
Octreotide—Oedema—Doxorubicin—breast cancer	4.37e-05	8.94e-05	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—breast cancer	4.37e-05	8.94e-05	CcSEcCtD
Octreotide—Gastrointestinal disorder—Methotrexate—breast cancer	4.36e-05	8.91e-05	CcSEcCtD
Octreotide—Fatigue—Methotrexate—breast cancer	4.35e-05	8.9e-05	CcSEcCtD
Octreotide—Infection—Doxorubicin—breast cancer	4.34e-05	8.88e-05	CcSEcCtD
Octreotide—Pain—Methotrexate—breast cancer	4.32e-05	8.82e-05	CcSEcCtD
Octreotide—Vomiting—Capecitabine—breast cancer	4.31e-05	8.81e-05	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Epirubicin—breast cancer	4.3e-05	8.8e-05	CcSEcCtD
Octreotide—Shock—Doxorubicin—breast cancer	4.3e-05	8.79e-05	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—breast cancer	4.29e-05	8.76e-05	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—breast cancer	4.28e-05	8.75e-05	CcSEcCtD
Octreotide—Rash—Capecitabine—breast cancer	4.28e-05	8.74e-05	CcSEcCtD
Octreotide—Insomnia—Epirubicin—breast cancer	4.27e-05	8.73e-05	CcSEcCtD
Octreotide—Dermatitis—Capecitabine—breast cancer	4.27e-05	8.73e-05	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—breast cancer	4.27e-05	8.72e-05	CcSEcCtD
Octreotide—Headache—Capecitabine—breast cancer	4.25e-05	8.68e-05	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—breast cancer	4.25e-05	8.68e-05	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—breast cancer	4.24e-05	8.67e-05	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—breast cancer	4.23e-05	8.64e-05	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—breast cancer	4.21e-05	8.61e-05	CcSEcCtD
Octreotide—Somnolence—Epirubicin—breast cancer	4.2e-05	8.59e-05	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—breast cancer	4.17e-05	8.52e-05	CcSEcCtD
Octreotide—Nausea—Docetaxel—breast cancer	4.16e-05	8.5e-05	CcSEcCtD
Octreotide—Feeling abnormal—Methotrexate—breast cancer	4.16e-05	8.5e-05	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—breast cancer	4.16e-05	8.5e-05	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—breast cancer	4.13e-05	8.44e-05	CcSEcCtD
Octreotide—Decreased appetite—Epirubicin—breast cancer	4.11e-05	8.4e-05	CcSEcCtD
Octreotide—Gastrointestinal disorder—Epirubicin—breast cancer	4.08e-05	8.34e-05	CcSEcCtD
Octreotide—Fatigue—Epirubicin—breast cancer	4.07e-05	8.33e-05	CcSEcCtD
Octreotide—Pain—Epirubicin—breast cancer	4.04e-05	8.26e-05	CcSEcCtD
Octreotide—Constipation—Epirubicin—breast cancer	4.04e-05	8.26e-05	CcSEcCtD
Octreotide—Nausea—Capecitabine—breast cancer	4.03e-05	8.23e-05	CcSEcCtD
Octreotide—Urticaria—Methotrexate—breast cancer	4.01e-05	8.2e-05	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—breast cancer	3.99e-05	8.16e-05	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—breast cancer	3.99e-05	8.16e-05	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.98e-05	8.14e-05	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—breast cancer	3.95e-05	8.08e-05	CcSEcCtD
Octreotide—Paraesthesia—Doxorubicin—breast cancer	3.92e-05	8.02e-05	CcSEcCtD
Octreotide—Dyspnoea—Doxorubicin—breast cancer	3.9e-05	7.97e-05	CcSEcCtD
Octreotide—Feeling abnormal—Epirubicin—breast cancer	3.89e-05	7.96e-05	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—breast cancer	3.89e-05	7.94e-05	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—breast cancer	3.86e-05	7.9e-05	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—breast cancer	3.85e-05	7.87e-05	CcSEcCtD
Octreotide—Decreased appetite—Doxorubicin—breast cancer	3.8e-05	7.77e-05	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—breast cancer	3.77e-05	7.71e-05	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—breast cancer	3.77e-05	7.7e-05	CcSEcCtD
Octreotide—Urticaria—Epirubicin—breast cancer	3.75e-05	7.67e-05	CcSEcCtD
Octreotide—Pain—Doxorubicin—breast cancer	3.74e-05	7.64e-05	CcSEcCtD
Octreotide—Constipation—Doxorubicin—breast cancer	3.74e-05	7.64e-05	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—breast cancer	3.73e-05	7.63e-05	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—breast cancer	3.73e-05	7.63e-05	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—breast cancer	3.72e-05	7.6e-05	CcSEcCtD
Octreotide—Asthenia—Methotrexate—breast cancer	3.62e-05	7.4e-05	CcSEcCtD
Octreotide—Feeling abnormal—Doxorubicin—breast cancer	3.6e-05	7.36e-05	CcSEcCtD
Octreotide—Gastrointestinal pain—Doxorubicin—breast cancer	3.57e-05	7.31e-05	CcSEcCtD
Octreotide—Pruritus—Methotrexate—breast cancer	3.57e-05	7.3e-05	CcSEcCtD
Octreotide—Hypersensitivity—Epirubicin—breast cancer	3.48e-05	7.12e-05	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—breast cancer	3.47e-05	7.1e-05	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—breast cancer	3.47e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—breast cancer	3.47e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—breast cancer	3.47e-05	0.000113	CbGpPWpGaD
Octreotide—Abdominal pain—Doxorubicin—breast cancer	3.46e-05	7.06e-05	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—breast cancer	3.46e-05	7.06e-05	CcSEcCtD
Octreotide—Diarrhoea—Methotrexate—breast cancer	3.45e-05	7.06e-05	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NFKBIA—breast cancer	3.44e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGF—breast cancer	3.43e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—breast cancer	3.41e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH1—breast cancer	3.4e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGFR1—breast cancer	3.4e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—breast cancer	3.39e-05	0.00011	CbGpPWpGaD
Octreotide—Asthenia—Epirubicin—breast cancer	3.39e-05	6.93e-05	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ERBB3—breast cancer	3.37e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—breast cancer	3.37e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR2—breast cancer	3.37e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—breast cancer	3.35e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—breast cancer	3.35e-05	0.000109	CbGpPWpGaD
Octreotide—Pruritus—Epirubicin—breast cancer	3.34e-05	6.83e-05	CcSEcCtD
Octreotide—Dizziness—Methotrexate—breast cancer	3.34e-05	6.82e-05	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—APC—breast cancer	3.33e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—breast cancer	3.33e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—breast cancer	3.33e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—breast cancer	3.32e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—breast cancer	3.29e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGF—breast cancer	3.29e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—breast cancer	3.27e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—breast cancer	3.26e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—breast cancer	3.26e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—breast cancer	3.24e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—breast cancer	3.24e-05	0.000105	CbGpPWpGaD
Octreotide—Diarrhoea—Epirubicin—breast cancer	3.23e-05	6.61e-05	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TERT—breast cancer	3.23e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—breast cancer	3.23e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—breast cancer	3.22e-05	0.000105	CbGpPWpGaD
Octreotide—Hypersensitivity—Doxorubicin—breast cancer	3.22e-05	6.58e-05	CcSEcCtD
Octreotide—Vomiting—Methotrexate—breast cancer	3.21e-05	6.56e-05	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL6—breast cancer	3.21e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—breast cancer	3.2e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—breast cancer	3.19e-05	0.000104	CbGpPWpGaD
Octreotide—Rash—Methotrexate—breast cancer	3.18e-05	6.51e-05	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—breast cancer	3.18e-05	6.5e-05	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IGF1—breast cancer	3.18e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT2—breast cancer	3.17e-05	0.000103	CbGpPWpGaD
Octreotide—Headache—Methotrexate—breast cancer	3.16e-05	6.46e-05	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—EGFR—breast cancer	3.16e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—breast cancer	3.14e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR1—breast cancer	3.14e-05	0.000102	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—breast cancer	3.14e-05	6.41e-05	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—JUN—breast cancer	3.13e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—breast cancer	3.13e-05	0.000102	CbGpPWpGaD
Octreotide—Dizziness—Epirubicin—breast cancer	3.12e-05	6.39e-05	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ESR1—breast cancer	3.12e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—breast cancer	3.11e-05	0.000101	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—breast cancer	3.09e-05	6.32e-05	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HIF1A—breast cancer	3.09e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—breast cancer	3.08e-05	0.0001	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—breast cancer	3.05e-05	9.92e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—breast cancer	3.05e-05	9.92e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKBIA—breast cancer	3.05e-05	9.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—breast cancer	3.05e-05	9.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT2—breast cancer	3.04e-05	9.9e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1A—breast cancer	3.04e-05	9.88e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—breast cancer	3.03e-05	9.86e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—breast cancer	3.03e-05	9.86e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—breast cancer	3.02e-05	9.83e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH1—breast cancer	3.02e-05	9.81e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—breast cancer	3.02e-05	9.81e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—breast cancer	3.02e-05	9.81e-05	CbGpPWpGaD
Octreotide—Vomiting—Epirubicin—breast cancer	3e-05	6.14e-05	CcSEcCtD
Octreotide—Nausea—Methotrexate—breast cancer	3e-05	6.13e-05	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—breast cancer	2.99e-05	6.11e-05	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CAV1—breast cancer	2.99e-05	9.72e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—breast cancer	2.99e-05	9.71e-05	CbGpPWpGaD
Octreotide—Rash—Epirubicin—breast cancer	2.98e-05	6.09e-05	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—breast cancer	2.98e-05	6.08e-05	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MAPK8—breast cancer	2.97e-05	9.65e-05	CbGpPWpGaD
Octreotide—Headache—Epirubicin—breast cancer	2.96e-05	6.05e-05	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—AKT1—breast cancer	2.96e-05	9.62e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—breast cancer	2.96e-05	9.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—breast cancer	2.95e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—breast cancer	2.95e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—breast cancer	2.95e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—breast cancer	2.92e-05	9.51e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGF—breast cancer	2.92e-05	9.49e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—breast cancer	2.9e-05	9.42e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—breast cancer	2.89e-05	9.41e-05	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—breast cancer	2.89e-05	5.91e-05	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—NOS3—breast cancer	2.88e-05	9.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—breast cancer	2.88e-05	9.37e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—breast cancer	2.86e-05	9.31e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—breast cancer	2.85e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—breast cancer	2.83e-05	9.19e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKBIA—breast cancer	2.81e-05	9.14e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—breast cancer	2.81e-05	9.14e-05	CbGpPWpGaD
Octreotide—Nausea—Epirubicin—breast cancer	2.81e-05	5.74e-05	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NOTCH1—breast cancer	2.78e-05	9.06e-05	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—breast cancer	2.78e-05	5.68e-05	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—BRAF—breast cancer	2.77e-05	9.02e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—breast cancer	2.76e-05	8.98e-05	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—breast cancer	2.76e-05	5.63e-05	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—breast cancer	2.75e-05	5.63e-05	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—breast cancer	2.74e-05	8.92e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—breast cancer	2.74e-05	8.91e-05	CbGpPWpGaD
Octreotide—Headache—Doxorubicin—breast cancer	2.74e-05	5.6e-05	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—MDM2—breast cancer	2.73e-05	8.89e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—breast cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—breast cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—breast cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—breast cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RELA—breast cancer	2.71e-05	8.82e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—breast cancer	2.71e-05	8.82e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—breast cancer	2.7e-05	8.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT2—breast cancer	2.7e-05	8.78e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—breast cancer	2.69e-05	8.76e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGF—breast cancer	2.69e-05	8.75e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—breast cancer	2.69e-05	8.74e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—breast cancer	2.66e-05	8.65e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—breast cancer	2.66e-05	8.65e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—breast cancer	2.63e-05	8.56e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MDM2—breast cancer	2.62e-05	8.52e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAF1—breast cancer	2.61e-05	8.49e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—breast cancer	2.61e-05	8.48e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—breast cancer	2.6e-05	8.45e-05	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—breast cancer	2.6e-05	5.31e-05	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—breast cancer	2.59e-05	8.44e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK3—breast cancer	2.59e-05	8.43e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—breast cancer	2.58e-05	8.4e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—breast cancer	2.57e-05	8.36e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—breast cancer	2.57e-05	8.34e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—breast cancer	2.56e-05	8.32e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—breast cancer	2.56e-05	8.31e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—breast cancer	2.55e-05	8.29e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—breast cancer	2.55e-05	8.29e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—breast cancer	2.54e-05	8.26e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—breast cancer	2.54e-05	8.26e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—breast cancer	2.52e-05	8.19e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—breast cancer	2.51e-05	8.17e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—breast cancer	2.5e-05	8.12e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—breast cancer	2.49e-05	8.11e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT2—breast cancer	2.49e-05	8.1e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—breast cancer	2.48e-05	8.07e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—breast cancer	2.47e-05	8.03e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—breast cancer	2.46e-05	8.02e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—breast cancer	2.45e-05	7.97e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—breast cancer	2.45e-05	7.97e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—breast cancer	2.45e-05	7.95e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—breast cancer	2.44e-05	7.94e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—breast cancer	2.43e-05	7.92e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—breast cancer	2.43e-05	7.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—breast cancer	2.39e-05	7.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—breast cancer	2.39e-05	7.78e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—breast cancer	2.38e-05	7.74e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—breast cancer	2.38e-05	7.73e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—breast cancer	2.37e-05	7.71e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—breast cancer	2.37e-05	7.7e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—breast cancer	2.37e-05	7.7e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—breast cancer	2.36e-05	7.67e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—breast cancer	2.34e-05	7.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—breast cancer	2.34e-05	7.62e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—breast cancer	2.34e-05	7.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—breast cancer	2.33e-05	7.59e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—breast cancer	2.33e-05	7.58e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—breast cancer	2.33e-05	7.57e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MDM2—breast cancer	2.32e-05	7.56e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—breast cancer	2.32e-05	7.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—breast cancer	2.31e-05	7.52e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—breast cancer	2.31e-05	7.5e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1A—breast cancer	2.3e-05	7.49e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—breast cancer	2.3e-05	7.47e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—breast cancer	2.29e-05	7.45e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—breast cancer	2.28e-05	7.42e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—breast cancer	2.28e-05	7.41e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—breast cancer	2.26e-05	7.35e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—breast cancer	2.26e-05	7.35e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—breast cancer	2.26e-05	7.35e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—breast cancer	2.26e-05	7.35e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK8—breast cancer	2.25e-05	7.31e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—breast cancer	2.24e-05	7.29e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—breast cancer	2.22e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1A—breast cancer	2.21e-05	7.18e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—breast cancer	2.2e-05	7.16e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—breast cancer	2.17e-05	7.07e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—breast cancer	2.16e-05	7.02e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK8—breast cancer	2.15e-05	7.01e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—breast cancer	2.15e-05	7e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—breast cancer	2.15e-05	6.99e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MDM2—breast cancer	2.14e-05	6.97e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—breast cancer	2.14e-05	6.96e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—breast cancer	2.14e-05	6.95e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—breast cancer	2.13e-05	6.93e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—breast cancer	2.13e-05	6.92e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—breast cancer	2.12e-05	6.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—breast cancer	2.11e-05	6.88e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—breast cancer	2.1e-05	6.83e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—breast cancer	2.09e-05	6.79e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—breast cancer	2.09e-05	6.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—breast cancer	2.08e-05	6.76e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—breast cancer	2.08e-05	6.75e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—breast cancer	2.08e-05	6.75e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—breast cancer	2.07e-05	6.73e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—breast cancer	2.07e-05	6.72e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—breast cancer	2.05e-05	6.68e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—breast cancer	2.04e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—breast cancer	2.02e-05	6.58e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—breast cancer	2.02e-05	6.57e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—breast cancer	2.01e-05	6.52e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—breast cancer	2e-05	6.52e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—breast cancer	1.99e-05	6.48e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—breast cancer	1.99e-05	6.47e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—breast cancer	1.98e-05	6.44e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—breast cancer	1.97e-05	6.41e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—breast cancer	1.97e-05	6.39e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—breast cancer	1.96e-05	6.39e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—breast cancer	1.96e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1A—breast cancer	1.96e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—breast cancer	1.95e-05	6.35e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—breast cancer	1.94e-05	6.3e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—breast cancer	1.92e-05	6.24e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—breast cancer	1.92e-05	6.23e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK8—breast cancer	1.91e-05	6.22e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—breast cancer	1.91e-05	6.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—breast cancer	1.91e-05	6.2e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—breast cancer	1.91e-05	6.2e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—breast cancer	1.9e-05	6.2e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—breast cancer	1.89e-05	6.16e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—breast cancer	1.88e-05	6.12e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—breast cancer	1.87e-05	6.08e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—breast cancer	1.87e-05	6.07e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—breast cancer	1.86e-05	6.06e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—breast cancer	1.85e-05	6.02e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—breast cancer	1.83e-05	5.95e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—breast cancer	1.83e-05	5.94e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—breast cancer	1.81e-05	5.9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—breast cancer	1.81e-05	5.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1A—breast cancer	1.81e-05	5.88e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—breast cancer	1.8e-05	5.86e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—breast cancer	1.79e-05	5.82e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—breast cancer	1.76e-05	5.74e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—breast cancer	1.76e-05	5.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK8—breast cancer	1.76e-05	5.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—breast cancer	1.76e-05	5.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—breast cancer	1.75e-05	5.68e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—breast cancer	1.75e-05	5.68e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—breast cancer	1.69e-05	5.5e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—breast cancer	1.67e-05	5.44e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—breast cancer	1.67e-05	5.43e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—breast cancer	1.63e-05	5.3e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—breast cancer	1.62e-05	5.28e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—breast cancer	1.62e-05	5.27e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—breast cancer	1.62e-05	5.27e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—breast cancer	1.61e-05	5.24e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—breast cancer	1.59e-05	5.16e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—breast cancer	1.57e-05	5.1e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—breast cancer	1.55e-05	5.05e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—breast cancer	1.54e-05	5.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—breast cancer	1.5e-05	4.89e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—breast cancer	1.5e-05	4.88e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—breast cancer	1.5e-05	4.88e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—breast cancer	1.5e-05	4.87e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—breast cancer	1.49e-05	4.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—breast cancer	1.47e-05	4.77e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—breast cancer	1.44e-05	4.68e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—breast cancer	1.44e-05	4.67e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—breast cancer	1.38e-05	4.5e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—breast cancer	1.38e-05	4.48e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—breast cancer	1.38e-05	4.48e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—breast cancer	1.33e-05	4.34e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—breast cancer	1.32e-05	4.31e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—breast cancer	1.28e-05	4.15e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—breast cancer	1.27e-05	4.14e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—breast cancer	1.27e-05	4.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—breast cancer	1.23e-05	4e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—breast cancer	1.22e-05	3.97e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—breast cancer	1.18e-05	3.83e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—breast cancer	1.13e-05	3.66e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—breast cancer	1.13e-05	3.66e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—breast cancer	1.04e-05	3.38e-05	CbGpPWpGaD
